The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Discover Which Altcoins Have Sustainable Tokenomics and how durable economic designs support continued use and value.
26,726 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
ServiceNow faced real headwinds long before the AI hype. This article breaks down the root causes, their impact on ma...
Markets that did not ride the pandemic rush are delivering resilience as higher rates persist. New data show how the ...
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Microsoft is not shrinking its ambitions. In this deep dive, we explore how the tech giant aims to reset its gaming d...
OpenAI's Sam Altman defended AI energy use at a major industry summit, arguing the footprint must be viewed against h...
Marvell faces a pivotal year as data centers, 5G networks, and AI workloads shape demand. This guide breaks down what...
Micron stock is gaining today as analysts turn more constructive and data-center demand shows resilience. This articl...
A high-profile crypto photo shoot has reignited debates about credibility, PR tactics, and the road ahead for a marke...
When a seasoned media veteran weighs in on CNN, it’s more than a rumor. This article translates that talk into action...
When markets wobble, patient investors can unlock real opportunities. This guide breaks down a clear process to spot ...
The crypto industry is cooling as funding tightens and demand wavers. Syndicate Labs shuts down amid a wave of cost c...